Serum Interleukin 6 Level is Associated With Overall Survival and Treatment Response in Gastric and Gastroesophageal Junction Cancer.

John D Karalis,Michelle R Ju,Lynn Y Yoon,Esther C Castro-Dubon,Scott I Reznik,Suntrea T G Hammer,Matthew R Porembka,Sam C Wang

Annals of surgery（2023）

引用 0|浏览5

暂无评分

摘要

Pre-treatment serum level of IL-6 is a promising prognostic biomarker for G+GEJ patients. Comparing pre- and post-neoadjuvant IL-6 levels may predict pathologic response to neoadjuvant therapy.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要